Get the Stockscreener App
0.00
100.00%
-0.0035
Geovax Labs Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
See More
Previous Close:
$0.0035
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.228
Geovax Labs Inc Stock (GOVXW) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678 384 7220
Address
1900 Lake Park Drive, Suite 380, Smyrna
Compare GOVXW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVXW
Geovax Labs Inc
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.90 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.27 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.42 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
815.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.15 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Geovax Labs Inc Stock (GOVXW) Latest News
Is GeoVax Labs Inc. a candidate for recovery play2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Is GeoVax Labs Inc. Equity Warrant stock a contrarian buyMarket Performance Report & Expert Approved Momentum Trade Ideas - newser.com
How to integrate GeoVax Labs Inc. Equity Warrant into portfolio analysis tools2025 Top Gainers & Reliable Volume Spike Alerts - newser.com
How GeoVax Labs Inc. Equity Warrant stock benefits from global expansionTrade Performance Summary & Low Volatility Stock Suggestions - newser.com
Real time scanner hits for GeoVax Labs Inc. explainedPortfolio Performance Summary & Short-Term Swing Trade Alerts - newser.com
What analysts say about GeoVax Labs Inc Equity Warrant stock - earlytimes.in
Key metrics from GeoVax Labs Inc. Equity Warrant’s quarterly dataIPO Watch & Target Return Focused Picks - newser.com
Is GeoVax Labs Inc. forming a bottoming baseEarnings Trend Report & Long-Term Growth Portfolio Plans - newser.com
What moving averages say about GeoVax Labs Inc. Equity WarrantJuly 2025 Review & Capital Protection Trading Alerts - newser.com
Why GeoVax Labs Inc. stock could be next big winner2025 Risk Factors & Trade Opportunity Analysis Reports - newser.com
Does GeoVax Labs Inc. fit your quant trading model2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Can GeoVax Labs Inc. Equity Warrant stock hit analyst price targets2025 Investor Takeaways & Capital Efficiency Focused Strategies - newser.com
Is GeoVax Labs Inc. Equity Warrant stock affected by interest rate hikesJuly 2025 Final Week & AI Driven Stock Movement Reports - newser.com
Custom watchlist performance reports with GeoVax Labs Inc.Market Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
GeoVax Executives to Pursue European Partnerships for Vaccine and Cancer Therapy Development - citybuzz
How to monitor GeoVax Labs Inc. Equity Warrant with trend dashboards2025 AllTime Highs & Consistent Return Investment Signals - newser.com
Historical volatility pattern of GeoVax Labs Inc. visualizedTrade Signal Summary & Weekly High Return Stock Forecasts - newser.com
Is GeoVax Labs Inc. stock supported by strong fundamentalsIPO Watch & Free Fast Entry Momentum Trade Alerts - newser.com
GeoVax Leadership to Participate in Key European Meetings to Advance Partnering Discussions - Yahoo Finance
Price action breakdown for GeoVax Labs Inc. Equity Warrant2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Chart based analysis of GeoVax Labs Inc. Equity Warrant trendsPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Comparing GeoVax Labs Inc. in custom built stock radarsQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Will GeoVax Labs Inc. continue its uptrendQuarterly Portfolio Report & Consistent Growth Equity Picks - newser.com
GeoVax Labs Inc Stock Analysis and ForecastInstitutional Holding Changes & Budget Friendly Trading Strategies - earlytimes.in
Statistical indicators supporting GeoVax Labs Inc.’s strengthPortfolio Performance Summary & Community Driven Trade Alerts - newser.com
Will GeoVax Labs Inc. Equity Warrant see short term momentumJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Why GeoVax Labs Inc. Equity Warrant stock attracts global investorsEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
GeoVax Labs Inc. stock trend forecastJuly 2025 Opening Moves & Stock Market Timing Techniques - newser.com
GeoVax to Present COVID-19 Vaccine Data for Immunocompromised Patients at European Vaccine Congress - citybuzz
GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025 - Yahoo Finance
Can trapped investors hope for a rebound in GeoVax Labs Inc.2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Published on: 2025-10-09 06:58:36 - newser.com
What candlestick patterns are forming on GeoVax Labs Inc.Trade Analysis Report & Expert Curated Trade Setup Alerts - newser.com
Backtesting results for GeoVax Labs Inc. Equity Warrant trading strategiesJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
GeoVax CEO to Present Pipeline Progress at ROTH Healthcare Conference - citybuzz
GeoVax to Participate in the 4th Annual ROTH Healthcare Opportunities Conference - Yahoo Finance
Geovax Labs Inc Stock (GOVXW) Financials Data
There is no financial data for Geovax Labs Inc (GOVXW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
4.09%
0.09%
Cap:
|
Volume (24h):